BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013;23:512-521. [PMID: 24013023 DOI: 10.1016/j.semcancer.2013.08.005] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Ren X, Du Y, You L, Zhao Y. Potential functions and implications of circular RNA in gastrointestinal cancer. Oncol Lett 2017;14:7016-20. [PMID: 29344130 DOI: 10.3892/ol.2017.7118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yang W, Ma J, Zhou W, Zhou X, Cao B, Fan D, Hong L. Biological implications and clinical value of mir-210 in gastrointestinal cancer. Expert Review of Gastroenterology & Hepatology 2017;11:539-48. [DOI: 10.1080/17474124.2017.1309281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 de Oliveira Junior WE, Felix TF, Pires GDV, Lapa RML, Severino FE, Terra SA, Lourenção PLTA, Dos Reis PP, Ortolan EVP. MicroRNA expression profiles in the esophagus of children with caustic stenosis: A pathway towards esophageal cancer? J Pediatr Surg 2020;55:2144-9. [PMID: 32111433 DOI: 10.1016/j.jpedsurg.2020.02.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Sun J, Song K, Feng X, Gao S. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma. Biochem Biophys Res Commun. 2016;473:363-369. [PMID: 26777997 DOI: 10.1016/j.bbrc.2016.01.042] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
5 Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang Z, Zhang H, Zhao Q, Fan D, Hong L. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets. 2017;21:1063-1075. [PMID: 28994330 DOI: 10.1080/14728222.2017.1389900] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
6 Tang J, Li Z, Zhu Q, Wen W, Wang J, Xu J, Wu W, Zhu Y, Xu H, Chen L. miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting IL-11 in esophageal squamous cell carcinoma. J Cell Physiol 2020;235:3043-55. [PMID: 31544245 DOI: 10.1002/jcp.29209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zeng RJ, Zheng CW, Gu JE, Zhang HX, Xie L, Xu LY, Li EM. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes. Mol Oncol 2019;13:2010-30. [PMID: 31314174 DOI: 10.1002/1878-0261.12548] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
8 Liu Y, Zhi Y, Song H, Zong M, Yi J, Mao G, Chen L, Huang G. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. J Exp Clin Cancer Res. 2019;38:369. [PMID: 31438989 DOI: 10.1186/s13046-019-1369-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
9 Gao H, Teng C, Huang W, Peng J, Wang C. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling. Int J Mol Sci 2015;16:21643-57. [PMID: 26370982 DOI: 10.3390/ijms160921643] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
10 Wu HT, Chen WT, Li GW, Shen JX, Ye QQ, Zhang ML, Chen WJ, Liu J. Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction. Front Genet 2019;10:1328. [PMID: 32038705 DOI: 10.3389/fgene.2019.01328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Vrana D, Hlavac V, Brynychova V, Vaclavikova R, Neoral C, Vrba J, Aujesky R, Matzenauer M, Melichar B, Soucek P. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. Int J Mol Sci 2018;19:E868. [PMID: 29543757 DOI: 10.3390/ijms19030868] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Liu YP, Cao Q, Li L, Zhang M. High expression of spermatogenesis associated serine rich 2 promotes tumorigenicity in esophageal squamous cell carcinoma cells and is associated with poor patient prognosis. Exp Ther Med 2021;22:698. [PMID: 33986862 DOI: 10.3892/etm.2021.10130] [Reference Citation Analysis]
13 Chiam K, Mayne GC, Watson DI, Woodman RJ, Bright TF, Michael MZ, Karapetis CS, Irvine T, Phillips WA, Hummel R, Wang T, Pimlott LK, Marri S, Astill DS, Ruszkiewicz AR, Thompson SK, Hussey DJ. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing. Ann Surg Oncol 2018;25:2731-8. [PMID: 29987600 DOI: 10.1245/s10434-018-6626-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
14 Pusung M, Zeki S, Fitzgerald R. Genomics of Esophageal Cancer and Biomarkers for Early Detection. Adv Exp Med Biol 2016;908:237-63. [PMID: 27573775 DOI: 10.1007/978-3-319-41388-4_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Han N, Zhao W, Zhang Z, Zheng P. MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. Biochem Biophys Res Commun 2016;470:175-80. [PMID: 26773497 DOI: 10.1016/j.bbrc.2016.01.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
16 Farid SG, Morris-Stiff G. "OMICS" technologies and their role in foregut primary malignancies. Curr Probl Surg. 2015;52:409-441. [PMID: 26527526 DOI: 10.1067/j.cpsurg.2015.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
17 Wu W, Huang B, Yan Y, Zhong ZQ. Exploration of gene functions for esophageal squamous cell carcinoma using network-based guilt by association principle. Braz J Med Biol Res 2018;51:e6801. [PMID: 29694510 DOI: 10.1590/1414-431x20186801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Mahawongkajit P, Tomtitchong P. Expression of miRNA in 5-FU resistant esophageal cancer. Mol Clin Oncol 2020;13:221-7. [PMID: 32714549 DOI: 10.3892/mco.2020.2070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhai R, Wei Y, Su L, Liu G, Kulke MH, Wain JC, Christiani DC. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status. Carcinogenesis 2015;36:87-93. [PMID: 25381453 DOI: 10.1093/carcin/bgu228] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
20 Li Q, Dai Z, Xia C, Jin L, Chen X. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis. Mol Cell Biochem 2020;470:165-74. [PMID: 32468237 DOI: 10.1007/s11010-020-03759-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Wang W, Fu S, Lin X, Zheng J, Pu J, Gu Y, Deng W, Liu Y, He Z, Liang W, Wang C. miR-92b-3p Functions As A Key Gene In Esophageal Squamous Cell Cancer As Determined By Co-Expression Analysis. Onco Targets Ther 2019;12:8339-53. [PMID: 31686859 DOI: 10.2147/OTT.S220823] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
22 Odenthal M, Hee J, Gockel I, Sisic L, Schmitz J, Stoecklein NH, Driemel C, Möhlendick B, Schmidt T, Knoefel WT, Lang H, Büttner R, Ott K, Vallböhmer D. Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction: Serum microRNA profiles as prognostic markers. Int J Cancer 2015;137:230-7. [DOI: 10.1002/ijc.29363] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
23 Liu C, Zhang YH, Deng Q, Li Y, Huang T, Zhou S, Cai YD. Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma. Biomed Res Int 2017;2017:3859582. [PMID: 28280730 DOI: 10.1155/2017/3859582] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
24 Chen Z, Liu Y, Qi B, Gu C, Wei X, Guo L, Yao W, Zhao B. MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells. Mol Med Rep 2019;20:3633-41. [PMID: 31485658 DOI: 10.3892/mmr.2019.10647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ramzan Z, Nassri AB, Huerta S. The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression. Expert Rev Mol Diagn 2014;14:575-91. [PMID: 24831686 DOI: 10.1586/14737159.2014.919856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Du J, Liu X, Wu Y, Zhu J, Tang Y. Essential role of STX6 in esophageal squamous cell carcinoma growth and migration. Biochem Biophys Res Commun 2016;472:60-7. [PMID: 26906622 DOI: 10.1016/j.bbrc.2016.02.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Bibby BA, Reynolds JV, Maher SG. MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma. PLoS One 2015;10:e0134180. [PMID: 26221725 DOI: 10.1371/journal.pone.0134180] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
28 Lynam-Lennon N, Bibby BA, Mongan AM, Marignol L, Paxton CN, Geiersbach K, Bronner MP, O'Sullivan J, Reynolds J, Maher SG. Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma. Mol Med 2016;22. [PMID: 27254108 DOI: 10.2119/molmed.2016.00020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
29 Yang Y, Fan X, Ren Y, Wu K, Tian X, Wen F, Liu D, Fan Y, Zhao S. SOX2-Upregulated microRNA-30e Promotes the Progression of Esophageal Cancer via Regulation of the USP4/SMAD4/CK2 Axis. Mol Ther Nucleic Acids 2021;23:200-14. [PMID: 33376627 DOI: 10.1016/j.omtn.2020.10.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update. Dis Esophagus 2017;30:1-9. [PMID: 27003597 DOI: 10.1111/dote.12489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
31 Zeng JH, Xiong DD, Pang YY, Zhang Y, Tang RX, Luo DZ, Chen G. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases. Oncotarget 2017;8:35681-99. [PMID: 28415685 DOI: 10.18632/oncotarget.16051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
32 Kestens C, Siersema PD, van Baal JW. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World J Gastroenterol 2016; 22(1): 1-7 [PMID: 26755856 DOI: 10.3748/wjg.v22.i1.1] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sharma B, Kanwar SS. Phosphatidylserine: A cancer cell targeting biomarker. Seminars in Cancer Biology 2018;52:17-25. [DOI: 10.1016/j.semcancer.2017.08.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 15.8] [Reference Citation Analysis]
34 Xu J, Wang J, Liu L, Chen L, Hu S, Liu F. MicroRNA -196b is related to the overall survival of patients with esophageal squamous cell carcinoma and facilitates tumor progression by regulating SOCS2 (Suppressor Of Cytokine Signaling 2). Bioengineered 2021;12:7737-46. [PMID: 34605350 DOI: 10.1080/21655979.2021.1982329] [Reference Citation Analysis]
35 Wang AH, Liu Y, Wang B, He YX, Fang YX, Yan YP. Epidemiological studies of esophageal cancer in the era of genome-wide association studies. World J Gastrointest Pathophysiol 2014; 5(3): 335-343 [PMID: 25133033 DOI: 10.4291/wjgp.v5.i3.335] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
36 Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA, Andl CD. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells. Mol Cancer 2015;14. [DOI: 10.1186/s12943-014-0284-y] [Reference Citation Analysis]
37 Wang Y, Chen X, Li J, Xia C. Quercetin Antagonizes Esophagus Cancer by Modulating miR-1-3p/TAGLN2 Pathway-Dependent Growth and Metastasis. Nutr Cancer 2021;:1-10. [PMID: 34498538 DOI: 10.1080/01635581.2021.1972125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ma G, Zhang F, Dong X, Wang X, Ren Y. Low expression of microRNA-202 is associated with the metastasis of esophageal squamous cell carcinoma. Exp Ther Med 2016;11:951-6. [PMID: 26998018 DOI: 10.3892/etm.2016.3014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
39 Zhang J, Chen D, Liang S, Wang J, Liu C, Nie C, Shan Z, Wang L, Fan Q, Wang F. miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC. Oncol Lett 2018;15:4619-26. [PMID: 29552108 DOI: 10.3892/ol.2018.7861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
40 Tsutsui M, Kawakubo H, Hayashida T, Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, Takeuchi H, Kitagawa Y. Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinoma. Int J Oncol 2015;47:867-74. [PMID: 26202837 DOI: 10.3892/ijo.2015.3085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
41 Cui D, Zhu Y, Yan D, Lee NPY, Han L, Law S, Tsao GSW, Cheung ALM. Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma. Carcinogenesis 2021;42:995-1007. [PMID: 34089582 DOI: 10.1093/carcin/bgab046] [Reference Citation Analysis]
42 Matsuzaki J, Suzuki H. MicroRNAs in Barrett's esophagus: future prospects. Front Genet 2014;5:69. [PMID: 24765103 DOI: 10.3389/fgene.2014.00069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
43 He Y, Hua R, Li B, Gu H, Sun Y, Li Z. Loss of FBP1 promotes proliferation, migration, and invasion by regulating fatty acid metabolism in esophageal squamous cell carcinoma. Aging (Albany NY) 2020;13:4986-98. [PMID: 33232284 DOI: 10.18632/aging.103916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chen Z, Che D, Gu X, Lin J, Deng J, Jiang P, Xu K, Xu B, Zhang T. Upregulation of PEDF Predicts a Poor Prognosis and Promotes Esophageal Squamous Cell Carcinoma Progression by Modulating the MAPK/ERK Signaling Pathway. Front Oncol 2021;11:625612. [PMID: 33718190 DOI: 10.3389/fonc.2021.625612] [Reference Citation Analysis]
45 Huang Z, Wang C, Zhao X. circFIG 4 drives the carcinogenesis and metastasis of esophagus cancer via the miR-493-5p/E2F3 axis. Thorac Cancer 2022. [PMID: 35083866 DOI: 10.1111/1759-7714.14321] [Reference Citation Analysis]
46 Hu R, Bi R, Jiang L, Xiao H, Xie X, Liu H, Hu F. LncRNA RP11-465B22.8 triggers esophageal cancer progression by targeting miR-765/KLK4 axis. Cell Death Discov 2021;7:262. [PMID: 34561425 DOI: 10.1038/s41420-021-00631-9] [Reference Citation Analysis]
47 di Pietro M, Chan D, Fitzgerald RC, Wang KK. Screening for Barrett's Esophagus. Gastroenterology 2015;148:912-23. [PMID: 25701083 DOI: 10.1053/j.gastro.2015.02.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
48 Wu WK, Sung JJ. Focus on gastrointestinal and liver cancers. Semin Cancer Biol 2013;23:469-70. [PMID: 24095959 DOI: 10.1016/j.semcancer.2013.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R. LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1. Onco Targets Ther 2018;11:639-49. [PMID: 29430188 DOI: 10.2147/OTT.S157638] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
50 Wang K, Chen D, Meng Y, Xu J, Zhang Q. Clinical evaluation of 4 types of microRNA in serum as biomarkers of esophageal squamous cell carcinoma. Oncol Lett. 2018;16:1196-1204. [PMID: 29963194 DOI: 10.3892/ol.2018.8720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
51 Zhou R, Tang X, Li L, Zhang F, Sun J, Ju C, Zhou Y, Liu R, Liang Y, Lv B, Zhang Z, Hu H, Lv XB. Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:531-9. [PMID: 32021462 DOI: 10.2147/CMAR.S232632] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bollschweiler E, Hölscher AH, Schmidt M, Warnecke-Eberz U. Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment. Chin J Cancer Res 2015;27:221-30. [PMID: 26157318 DOI: 10.3978/j.issn.1000-9604.2015.04.04] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
53 Petrick JL, Pfeiffer RM, Liao LM, Abnet CC, Wu X, Gammon MD, Vaughan TL, Cook MB. Circulating MicroRNAs in Relation to Esophageal Adenocarcinoma Diagnosis and Survival. Dig Dis Sci 2021. [PMID: 33403483 DOI: 10.1007/s10620-020-06740-2] [Reference Citation Analysis]
54 Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, Nicot C. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer 2022;21:87. [PMID: 35346215 DOI: 10.1186/s12943-022-01548-2] [Reference Citation Analysis]
55 Wang M, Wang L, Zhang M, Li X, Zhu Z, Wang H. MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B. Biomedicine & Pharmacotherapy 2017;95:1678-83. [DOI: 10.1016/j.biopha.2017.09.048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
56 Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev 2016;25:429-37. [PMID: 26604271 DOI: 10.1158/1055-9965.EPI-15-0161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
57 Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ, Cao XF. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14:3. [PMID: 25608466 DOI: 10.1186/1476-4598-14-3] [Cited by in Crossref: 197] [Cited by in F6Publishing: 199] [Article Influence: 28.1] [Reference Citation Analysis]
58 Wang L, Cao N, Wang S, Man H, Li P, Shan B. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma. Tumor Biol 2016;37:2961-71. [DOI: 10.1007/s13277-015-4132-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
59 Harrandah AM, Mora RA, Chan EK. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Letters 2018;438:126-32. [DOI: 10.1016/j.canlet.2018.09.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
60 Lin D, Chen X, Tan L. The predictive value of microRNAs for pathological response after neoadjuvant treatment in esophageal squamous cell carcinoma: a systematic review. Ann Transl Med 2021;9:420. [PMID: 33842641 DOI: 10.21037/atm-20-3000] [Reference Citation Analysis]
61 Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, Fitzgerald RC, Bernstein L, Ye W, Bird NC, Romero Y, Casson AG, Corley DA, Shaheen NJ, Wu AH, Gammon MD, Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One 2015;10:e0128617. [PMID: 26039359 DOI: 10.1371/journal.pone.0128617] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
62 Li XM, Wang H, Zhu LL, Zhao RZ, Ji HL. Genes Regulating Epithelial Polarity Are Critical Suppressors of Esophageal Oncogenesis. J Cancer 2015;6:694-700. [PMID: 26185530 DOI: 10.7150/jca.11709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
63 Liao J, Liu R, Yin L, Pu Y. Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing. Int J Mol Sci. 2014;15:15530-15551. [PMID: 25184951 DOI: 10.3390/ijms150915530] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
64 Ma Y, Wang B, Guo Y, Zhang Y, Huang S, Bao X, Bai M. Inhibition of miR-196a affects esophageal cancer cell growth in vitro. Biomedicine & Pharmacotherapy 2016;84:22-7. [DOI: 10.1016/j.biopha.2016.09.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
65 Gao X, Liu Q, Chen X, Chen S, Yang J, Liu Q, Cheng Y. Screening of tumor grade-related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma. J Clin Lab Anal 2021;35:e23797. [PMID: 33960436 DOI: 10.1002/jcla.23797] [Reference Citation Analysis]
66 Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA, Andl CD. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells. Mol Cancer. 2015;14:24. [PMID: 25644061 DOI: 10.1186/s12943-014-0284-y] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 9.9] [Reference Citation Analysis]
67 Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016;15:39. [PMID: 27189224 DOI: 10.1186/s12943-016-0524-4] [Cited by in Crossref: 158] [Cited by in F6Publishing: 168] [Article Influence: 26.3] [Reference Citation Analysis]
68 Chen Q, Hou J, Wu Z, Zhao J, Ma. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L. Pathol Res Pract 2019;215:152427. [PMID: 31072625 DOI: 10.1016/j.prp.2019.04.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
69 Miao Y, Liu R, Pu Y, Yin L. Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: A bibliometric analysis. Medicine (Baltimore) 2017;96:e6924. [PMID: 28514311 DOI: 10.1097/MD.0000000000006924] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
70 Bennett M, Mashimo H. Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 438-449 [PMID: 25400987 DOI: 10.4291/wjgp.v5.i4.438] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
71 Cui D, Cheung AL. Roles of microRNAs in tumorigenesis and metastasis of esophageal squamous cell carcinoma. World J Clin Oncol 2021; 12(8): 609-622 [PMID: 34513596 DOI: 10.5306/wjco.v12.i8.609] [Reference Citation Analysis]
72 Sun C, Zhang X, Chen Y, Jia Q, Yang J, Shu Y. MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1. Cancer Manag Res 2018;10:4581-90. [PMID: 30410394 DOI: 10.2147/CMAR.S157858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
73 Fan YX, Bian XH, Qian PD, Chen ZZ, Wen J, Luo YH, Yan PW, Zhang Q. MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF. Oncol Rep 2018;40:61-72. [PMID: 29749531 DOI: 10.3892/or.2018.6413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
74 Li F, Zhang L, Li W, Deng J, Zheng J, An M, Lu J, Zhou Y. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget. 2015;6:6001-6013. [PMID: 25749389 DOI: 10.18632/oncotarget.3469] [Cited by in Crossref: 389] [Cited by in F6Publishing: 452] [Article Influence: 64.8] [Reference Citation Analysis]
75 Zheng TL, Li DP, He ZF, Zhao S. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int 2019;19:250. [PMID: 31582906 DOI: 10.1186/s12935-019-0943-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
76 Cui X, Wang K, Yang X, Peng H, Chen X, Xin H, Tian Y, Chen Y, Li F. Comprehensive bioinformation analysis of the miRNA of PLCE1 knockdown in esophageal squamous cell carcinoma. Mol Cell Biochem 2018;442:111-27. [PMID: 29238898 DOI: 10.1007/s11010-017-3197-4] [Reference Citation Analysis]
77 Kim J, Ryu JK, Lee SH, Kim YT. MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers. Gut Liver 2016;10:836-41. [PMID: 27172928 DOI: 10.5009/gnl15460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
78 Kailasam A, Mittal SK, Agrawal DK. Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma. Clin Transl Sci 2015;8:394-402. [PMID: 25388215 DOI: 10.1111/cts.12242] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
79 Zhang Z, Li X, Xiong F, Ren Z, Han Y. Hsa_circ_0012563 promotes migration and invasion of esophageal squamous cell carcinoma by regulating XRCC1/EMT pathway. J Clin Lab Anal 2020;34:e23308. [PMID: 32185826 DOI: 10.1002/jcla.23308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
80 Yang W, Ma J, Zhou W, Zhou X, Cao B, Zhang H, Zhao Q, Fan D, Hong L. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Rev Gastroenterol Hepatol 2017;11:1151-63. [PMID: 28838272 DOI: 10.1080/17474124.2017.1372189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
81 Huang YQ. Molecular mechanisms responsible for pathogenesis of Barrett's esophagus. Shijie Huaren Xiaohua Zazhi 2013; 21(34): 3813-3820 [DOI: 10.11569/wcjd.v21.i34.3813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Wang CC, Li TH, Huang L, Chen X. Prediction of potential miRNA-disease associations based on stacked autoencoder. Brief Bioinform 2022:bbac021. [PMID: 35176761 DOI: 10.1093/bib/bbac021] [Reference Citation Analysis]